Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03324659 · ClinicalTrials.gov registry record · NA

Meditation and Exercise to Treat Chronic Back Pain

A NA study of Chronic Low Back Pain, sponsored by Duquesne University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT03324659: Completed NA study of Chronic Low Back Pain, sponsored by Duquesne University.

NCT03324659 is a NA study of Chronic Low Back Pain that has completed, run by Duquesne University. The registered enrollment target is 42 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03324659, a NA study of Chronic Low Back Pain, has completed, sponsored by Duquesne University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The investigators hypothesize that a combination treatment reduces disability and pain more than the control intervention.

Primary Outcome

The Roland-Morris Disability Questionnaire is designed to assess self-rated physical disability caused by low back pain. The patient is asked to tick a statement when it applies to him that specific day, this makes it possible to follow changes in time. The end score is the sum of the ticked boxes. The score ranges from 0 (no disability) to 24 (max. disability).

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Exercise and Meditation

Study Locations (1)

Pennsylvania

  • Duquesne University - Pittsburgh

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-01-26
Est. Completion 2019-06-30
Phase NA
Duquesne University

21 total trials

What the finished NCT03324659 record still lists

NCT03324659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03324659 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03324659 about?

NCT03324659 is a clinical study titled "Meditation and Exercise to Treat Chronic Back Pain". This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The inv...

What is the current status of trial NCT03324659?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-01-26. Estimated completion is 2019-06-30.

What conditions does trial NCT03324659 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT03324659?

The interventions under investigation include: Control (BEHAVIORAL), Exercise and Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03324659?

This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03324659 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03324659's enrollment target sits among peer trials

42 52nd of 71 higher than 19 of 71 other Chronic Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03324659, the US trial registry maintained by the National Library of Medicine. NCT03324659 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.